Cargando…

P1116: HIGH COMPLETE METABOLIC RESPONSE RATES WITH EPCORITAMAB + R-CHOP IN PREVIOUSLY UNTREATED (1L) PATIENTS WITH HIGH-RISK DIFFUSE LARGE B-CELL LYMPHOMA, INCLUDING DOUBLE/TRIPLE-HIT: EPCORE NHL-2 UPDATE

Detalles Bibliográficos
Autores principales: Roost Clausen, Michael, Belada, David, Offner, Fritz, de Vos, Sven, Brody, Joshua, Linton, Kim, Snauwaert, Sylvia, Cordoba, Raul, Wu, Jun, Bykhovski, Irina, Wang, Liwei, Rana, Ali, Falchi, Lorenzo
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Lippincott Williams & Wilkins 2023
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10431001/
http://dx.doi.org/10.1097/01.HS9.0000971360.55140.cd
_version_ 1785091094856335360
author Roost Clausen, Michael
Belada, David
Offner, Fritz
de Vos, Sven
Brody, Joshua
Linton, Kim
Snauwaert, Sylvia
Cordoba, Raul
Wu, Jun
Bykhovski, Irina
Wang, Liwei
Rana, Ali
Falchi, Lorenzo
author_facet Roost Clausen, Michael
Belada, David
Offner, Fritz
de Vos, Sven
Brody, Joshua
Linton, Kim
Snauwaert, Sylvia
Cordoba, Raul
Wu, Jun
Bykhovski, Irina
Wang, Liwei
Rana, Ali
Falchi, Lorenzo
author_sort Roost Clausen, Michael
collection PubMed
description
format Online
Article
Text
id pubmed-10431001
institution National Center for Biotechnology Information
language English
publishDate 2023
publisher Lippincott Williams & Wilkins
record_format MEDLINE/PubMed
spelling pubmed-104310012023-08-17 P1116: HIGH COMPLETE METABOLIC RESPONSE RATES WITH EPCORITAMAB + R-CHOP IN PREVIOUSLY UNTREATED (1L) PATIENTS WITH HIGH-RISK DIFFUSE LARGE B-CELL LYMPHOMA, INCLUDING DOUBLE/TRIPLE-HIT: EPCORE NHL-2 UPDATE Roost Clausen, Michael Belada, David Offner, Fritz de Vos, Sven Brody, Joshua Linton, Kim Snauwaert, Sylvia Cordoba, Raul Wu, Jun Bykhovski, Irina Wang, Liwei Rana, Ali Falchi, Lorenzo Hemasphere Posters Lippincott Williams & Wilkins 2023-08-08 /pmc/articles/PMC10431001/ http://dx.doi.org/10.1097/01.HS9.0000971360.55140.cd Text en Copyright © 2023 The Author(s). Published by Wolters Kluwer Health, Inc. https://creativecommons.org/licenses/by-nc-nd/4.0/This is an open access Abstract Book distributed under the Attribution-NonCommercial-NoDerivs (CC BY-NC-ND) (https://creativecommons.org/licenses/by-nc-nd/4.0/) which allows third parties to download the articles and share them with others as long as they credit the author and the Abstract Book, but they cannot change the content in any way or use them commercially.
spellingShingle Posters
Roost Clausen, Michael
Belada, David
Offner, Fritz
de Vos, Sven
Brody, Joshua
Linton, Kim
Snauwaert, Sylvia
Cordoba, Raul
Wu, Jun
Bykhovski, Irina
Wang, Liwei
Rana, Ali
Falchi, Lorenzo
P1116: HIGH COMPLETE METABOLIC RESPONSE RATES WITH EPCORITAMAB + R-CHOP IN PREVIOUSLY UNTREATED (1L) PATIENTS WITH HIGH-RISK DIFFUSE LARGE B-CELL LYMPHOMA, INCLUDING DOUBLE/TRIPLE-HIT: EPCORE NHL-2 UPDATE
title P1116: HIGH COMPLETE METABOLIC RESPONSE RATES WITH EPCORITAMAB + R-CHOP IN PREVIOUSLY UNTREATED (1L) PATIENTS WITH HIGH-RISK DIFFUSE LARGE B-CELL LYMPHOMA, INCLUDING DOUBLE/TRIPLE-HIT: EPCORE NHL-2 UPDATE
title_full P1116: HIGH COMPLETE METABOLIC RESPONSE RATES WITH EPCORITAMAB + R-CHOP IN PREVIOUSLY UNTREATED (1L) PATIENTS WITH HIGH-RISK DIFFUSE LARGE B-CELL LYMPHOMA, INCLUDING DOUBLE/TRIPLE-HIT: EPCORE NHL-2 UPDATE
title_fullStr P1116: HIGH COMPLETE METABOLIC RESPONSE RATES WITH EPCORITAMAB + R-CHOP IN PREVIOUSLY UNTREATED (1L) PATIENTS WITH HIGH-RISK DIFFUSE LARGE B-CELL LYMPHOMA, INCLUDING DOUBLE/TRIPLE-HIT: EPCORE NHL-2 UPDATE
title_full_unstemmed P1116: HIGH COMPLETE METABOLIC RESPONSE RATES WITH EPCORITAMAB + R-CHOP IN PREVIOUSLY UNTREATED (1L) PATIENTS WITH HIGH-RISK DIFFUSE LARGE B-CELL LYMPHOMA, INCLUDING DOUBLE/TRIPLE-HIT: EPCORE NHL-2 UPDATE
title_short P1116: HIGH COMPLETE METABOLIC RESPONSE RATES WITH EPCORITAMAB + R-CHOP IN PREVIOUSLY UNTREATED (1L) PATIENTS WITH HIGH-RISK DIFFUSE LARGE B-CELL LYMPHOMA, INCLUDING DOUBLE/TRIPLE-HIT: EPCORE NHL-2 UPDATE
title_sort p1116: high complete metabolic response rates with epcoritamab + r-chop in previously untreated (1l) patients with high-risk diffuse large b-cell lymphoma, including double/triple-hit: epcore nhl-2 update
topic Posters
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10431001/
http://dx.doi.org/10.1097/01.HS9.0000971360.55140.cd
work_keys_str_mv AT roostclausenmichael p1116highcompletemetabolicresponserateswithepcoritamabrchopinpreviouslyuntreated1lpatientswithhighriskdiffuselargebcelllymphomaincludingdoubletriplehitepcorenhl2update
AT beladadavid p1116highcompletemetabolicresponserateswithepcoritamabrchopinpreviouslyuntreated1lpatientswithhighriskdiffuselargebcelllymphomaincludingdoubletriplehitepcorenhl2update
AT offnerfritz p1116highcompletemetabolicresponserateswithepcoritamabrchopinpreviouslyuntreated1lpatientswithhighriskdiffuselargebcelllymphomaincludingdoubletriplehitepcorenhl2update
AT devossven p1116highcompletemetabolicresponserateswithepcoritamabrchopinpreviouslyuntreated1lpatientswithhighriskdiffuselargebcelllymphomaincludingdoubletriplehitepcorenhl2update
AT brodyjoshua p1116highcompletemetabolicresponserateswithepcoritamabrchopinpreviouslyuntreated1lpatientswithhighriskdiffuselargebcelllymphomaincludingdoubletriplehitepcorenhl2update
AT lintonkim p1116highcompletemetabolicresponserateswithepcoritamabrchopinpreviouslyuntreated1lpatientswithhighriskdiffuselargebcelllymphomaincludingdoubletriplehitepcorenhl2update
AT snauwaertsylvia p1116highcompletemetabolicresponserateswithepcoritamabrchopinpreviouslyuntreated1lpatientswithhighriskdiffuselargebcelllymphomaincludingdoubletriplehitepcorenhl2update
AT cordobaraul p1116highcompletemetabolicresponserateswithepcoritamabrchopinpreviouslyuntreated1lpatientswithhighriskdiffuselargebcelllymphomaincludingdoubletriplehitepcorenhl2update
AT wujun p1116highcompletemetabolicresponserateswithepcoritamabrchopinpreviouslyuntreated1lpatientswithhighriskdiffuselargebcelllymphomaincludingdoubletriplehitepcorenhl2update
AT bykhovskiirina p1116highcompletemetabolicresponserateswithepcoritamabrchopinpreviouslyuntreated1lpatientswithhighriskdiffuselargebcelllymphomaincludingdoubletriplehitepcorenhl2update
AT wangliwei p1116highcompletemetabolicresponserateswithepcoritamabrchopinpreviouslyuntreated1lpatientswithhighriskdiffuselargebcelllymphomaincludingdoubletriplehitepcorenhl2update
AT ranaali p1116highcompletemetabolicresponserateswithepcoritamabrchopinpreviouslyuntreated1lpatientswithhighriskdiffuselargebcelllymphomaincludingdoubletriplehitepcorenhl2update
AT falchilorenzo p1116highcompletemetabolicresponserateswithepcoritamabrchopinpreviouslyuntreated1lpatientswithhighriskdiffuselargebcelllymphomaincludingdoubletriplehitepcorenhl2update